<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(20)</volume><submitter>Kamdar M</submitter><funding>NCI NIH HHS</funding><journal>Blood advances</journal><pagination>3132-3135</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6849956</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma.</pubmed_title><pmcid>PMC6849956</pmcid><funding_grant_id>UG1 CA233324</funding_grant_id><funding_grant_id>U10 CA180819</funding_grant_id><funding_grant_id>UG1 CA233339</funding_grant_id><funding_grant_id>UG1 CA233160</funding_grant_id><funding_grant_id>U10 CA180888</funding_grant_id><funding_grant_id>UG1 CA233373</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Barr PM</pubmed_authors><pubmed_authors>Shea TC</pubmed_authors><pubmed_authors>Kamdar M</pubmed_authors><pubmed_authors>Friedberg JW</pubmed_authors><pubmed_authors>Fenske TS</pubmed_authors><pubmed_authors>Chen RW</pubmed_authors><pubmed_authors>Leblanc ML</pubmed_authors><pubmed_authors>Phillips TJ</pubmed_authors><pubmed_authors>Rimsza LM</pubmed_authors><pubmed_authors>Kahl BS</pubmed_authors><pubmed_authors>Leonard JP</pubmed_authors><pubmed_authors>Smith SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-19T09:12:00.657Z</modification><creation>2025-04-19T09:12:00.657Z</creation></dates><accession>S-EPMC6849956</accession><cross_references><pubmed>31648328</pubmed><doi>10.1182/bloodadvances.2019000526</doi></cross_references></HashMap>